Trademark: 97333983
Word
BIOLIFE CELLULAR THERAPY SERVICES
Status Date
Wednesday, February 7, 2024
Filing Date
Monday, March 28, 2022
Published for Opposition
Tuesday, August 30, 2022
44 Medical services, namely, cellular starter material collection services featuring human blood-derived biological raw materials that are eventually processed for biopharmaceutical uses and disease treatments
BIO LIFE CELLULAR THERAPY SERVICES
"CELLULAR THERAPY SERVICES"
Feb 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 7, 2024
Sou Extension 3 Granted
Feb 7, 2024
Sou Extension 3 Filed
Feb 7, 2024
Sou Teas Extension Received
Aug 31, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 29, 2023
Sou Extension 2 Granted
Aug 29, 2023
Sou Extension 2 Filed
Aug 29, 2023
Sou Teas Extension Received
Mar 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 13, 2023
Sou Extension 1 Granted
Mar 13, 2023
Sou Extension 1 Filed
Mar 13, 2023
Sou Teas Extension Received
Oct 25, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 30, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 30, 2022
Published For Opposition
Aug 10, 2022
Notification Of Notice Of Publication E-Mailed
Jul 26, 2022
Approved For Pub - Principal Register
Jul 26, 2022
Examiner's Amendment Entered
Jul 26, 2022
Assigned To Lie
Jul 25, 2022
Notification Of Examiners Amendment E-Mailed
Jul 25, 2022
Examiners Amendment E-Mailed
Jul 25, 2022
Examiners Amendment -Written
Jul 20, 2022
Teas/Email Correspondence Entered
Jul 19, 2022
Correspondence Received In Law Office
Jul 19, 2022
Teas Response To Office Action Received
Jun 26, 2022
Notification Of Non-Final Action E-Mailed
Jun 26, 2022
Non-Final Action E-Mailed
Jun 26, 2022
Non-Final Action Written
Jun 26, 2022
Assigned To Examiner
Apr 1, 2022
New Application Office Supplied Data Entered
Mar 31, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
